Charles DeCarli1, Sylvia Villeneuve2, Pauline Maillard1, Danielle Harvey3, Baljeet Singh1, Owen Carmichael4, Evan Fletcher1, John Olichney1, Sarah Farias1, William Jagust5, Bruce Reed6, Dan Mungas1. 1. UC Davis Department of Neurology and Center for Neuroscience, Davis, CA, USA. 2. Douglas Mental Health University Institute, McGill University, Montreal, Canada. 3. Division of Biostatistics, School of Medicine, University of California at Davis, Davis, CA, USA. 4. Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA. 5. Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley CA, USA. 6. Center for Scientific Review, Division of Neuroscience, Development and Aging, NIH, Bethesda, MD, USA.
Abstract
BACKGROUND/ OBJECTIVE: To determine the impact of vascular burden on rates of decline in episodic memory and executive function. We hypothesize that greater vascular burden will have an additive negative impact on cognition after accounting for baseline cognitive impairment, positron emission tomography (PET) amyloid burden, and magnetic resonance imaging (MRI) measures. METHODS: Individuals were followed an average of 5 years with serial cognitive assessments. Predictor variables include vascular burden score (VBS), quantitative brain MRI assessment, and amyloid imaging. Subjects consisted of 65 individuals, 53% of whom were male, aged 73.2±7.2 years on average with an average of 15.5±3.3 years of educational achievement. RESULTS: Baseline cognitive impairment was significantly associated poorer episodic memory (p < 0.0001), smaller hippocampal volume (p < 0.0001), smaller brain volume (p = 0.0026), and greater global Pittsburg Imaging Compound B (PiB) index (p = 0.0008). Greater amyloid burden was associated with greater decline in episodic memory over time (β= -0.20±0.07, p < 0.005). VBS was significantly associated with the level of executive function performance (β= -0.14±0.05, p < 0.005) and there was a significant negative interaction between VBS, cognitive impairment, and PiB index (β= -0.065±0.03, p = 0.03). CONCLUSIONS: Our results find a significant influence of VBS independent of standard MRI measures and cerebral amyloid burden on executive function. In addition, VBS reduced the amount of cerebral amyloid burden needed to result in cognitive impairment. We conclude that the systemic effects of vascular disease as reflected by the VBS independently influence cognitive ability.
BACKGROUND/ OBJECTIVE: To determine the impact of vascular burden on rates of decline in episodic memory and executive function. We hypothesize that greater vascular burden will have an additive negative impact on cognition after accounting for baseline cognitive impairment, positron emission tomography (PET) amyloid burden, and magnetic resonance imaging (MRI) measures. METHODS: Individuals were followed an average of 5 years with serial cognitive assessments. Predictor variables include vascular burden score (VBS), quantitative brain MRI assessment, and amyloid imaging. Subjects consisted of 65 individuals, 53% of whom were male, aged 73.2±7.2 years on average with an average of 15.5±3.3 years of educational achievement. RESULTS: Baseline cognitive impairment was significantly associated poorer episodic memory (p < 0.0001), smaller hippocampal volume (p < 0.0001), smaller brain volume (p = 0.0026), and greater global Pittsburg Imaging Compound B (PiB) index (p = 0.0008). Greater amyloid burden was associated with greater decline in episodic memory over time (β= -0.20±0.07, p < 0.005). VBS was significantly associated with the level of executive function performance (β= -0.14±0.05, p < 0.005) and there was a significant negative interaction between VBS, cognitive impairment, and PiB index (β= -0.065±0.03, p = 0.03). CONCLUSIONS: Our results find a significant influence of VBS independent of standard MRI measures and cerebral amyloid burden on executive function. In addition, VBS reduced the amount of cerebral amyloid burden needed to result in cognitive impairment. We conclude that the systemic effects of vascular disease as reflected by the VBS independently influence cognitive ability.
Authors: Clifford R Jack; David S Knopman; William J Jagust; Ronald C Petersen; Michael W Weiner; Paul S Aisen; Leslie M Shaw; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Vernon S Pankratz; Michael C Donohue; John Q Trojanowski Journal: Lancet Neurol Date: 2013-02 Impact factor: 44.182
Authors: Matthew P Pase; Jayandra J Himali; Gary F Mitchell; Alexa Beiser; Pauline Maillard; Connie Tsao; Martin G Larson; Charles DeCarli; Ramachandran S Vasan; Sudha Seshadri Journal: Hypertension Date: 2016-01-11 Impact factor: 10.190
Authors: Julie C Price; William E Klunk; Brian J Lopresti; Xueling Lu; Jessica A Hoge; Scott K Ziolko; Daniel P Holt; Carolyn C Meltzer; Steven T DeKosky; Chester A Mathis Journal: J Cereb Blood Flow Metab Date: 2005-11 Impact factor: 6.200
Authors: Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli Journal: Stroke Date: 2004-06-24 Impact factor: 7.914
Authors: Bruce Reed; Sylvia Villeneuve; Wendy Mack; Charles DeCarli; Helena C Chui; William Jagust Journal: JAMA Neurol Date: 2014-02 Impact factor: 18.302
Authors: Hussein N Yassine; Qingru Feng; Ida Azizkhanian; Varun Rawat; Katherine Castor; Alfred N Fonteh; Michael G Harrington; Ling Zheng; Bruce R Reed; Charles DeCarli; William J Jagust; Helena C Chui Journal: JAMA Neurol Date: 2016-10-01 Impact factor: 18.302
Authors: Matthew P Pase; Kendra Davis-Plourde; Jayandra J Himali; Claudia L Satizabal; Hugo Aparicio; Sudha Seshadri; Alexa S Beiser; Charles DeCarli Journal: Neurology Date: 2018-09-19 Impact factor: 11.800
Authors: Nutta-On Promjunyakul; David L Lahna; Jeffrey A Kaye; Hiroko H Dodge; Deniz Erten-Lyons; William D Rooney; Lisa C Silbert Journal: J Cereb Blood Flow Metab Date: 2016-06-07 Impact factor: 6.200
Authors: Matthew P Pase; Jayandra J Himali; Hugo J Aparicio; Jose Rafael Romero; Claudia L Satizabal; Pauline Maillard; Charles DeCarli; Alexa S Beiser; Sudha Seshadri Journal: Ann Neurol Date: 2019-07-29 Impact factor: 10.422
Authors: Diana Younan; Andrew J Petkus; Keith F Widaman; Xinhui Wang; Ramon Casanova; Mark A Espeland; Margaret Gatz; Victor W Henderson; JoAnn E Manson; Stephen R Rapp; Bonnie C Sachs; Marc L Serre; Sarah A Gaussoin; Ryan Barnard; Santiago Saldana; William Vizuete; Daniel P Beavers; Joel A Salinas; Helena C Chui; Susan M Resnick; Sally A Shumaker; Jiu-Chiuan Chen Journal: Brain Date: 2020-01-01 Impact factor: 13.501
Authors: Scott Nugent; Olivier Potvin; Stephen C Cunnane; Ting-Huei Chen; Simon Duchesne Journal: Front Aging Neurosci Date: 2020-10-30 Impact factor: 5.750
Authors: Ji Won Han; Pauline Maillard; Danielle Harvey; Evan Fletcher; Oliver Martinez; David K Johnson; John M Olichney; Sarah T Farias; Sylvia Villeneuve; William Jagust; Dan Mungas; Charles DeCarli Journal: Neurology Date: 2020-07-30 Impact factor: 9.910